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Background and aims: The cortisol/testosterone (C/T) ratio has been hypothesized to be a better predictor
of atherosclerosis than cortisol alone. No study has assessed whether the C/T and C/sex hormone-binding
globulin (SHBG) ratios are associated with atherosclerosis in a U.S. population sample.
Methods: This substudy included 367 women who had both cortisol from year 15 and testosterone and
SHBG at year 16 of the Coronary Artery Risk Development in Young Adults study, an ongoing observa-
tional cohort in the United States. Of these, intima-media thickness (IMT) was available at follow-up year
20 in 339 (n ¼ 332 with measurement at carotid bulb), and 303 were free of prevalent coronary artery
calcium (CAC) at year 15. Area under the curve (AUC) of salivary cortisol was available in 302 individuals.
Ratios of AUCs of cortisol to total testosterone, free testosterone, and SHBG were categorized into tertiles.
Associations with CAC and IMT were assessed by regression models adjusted for age, race, body mass
index, systolic blood pressure, menopause, oral contraceptive use, diabetes, alcohol, and smoking.
Results: Only the highest tertile of the AUC/free testosterone ratio was positively associated with carotid
bulb IMT (b ¼ 0.088, P ¼ 0.006). This tertile was also positively associated with new onset CAC between
year 15 and 25 (OR 3.45, 95% CI 1.18e10.06). Tertiles of cortisol or testosterone alone were not associated
with new onset CAC.
Conclusion: AUC/Free testosterone ratio may be more associated with atherosclerosis in women than
either indicator alone. The ratio may serve as a suitable biomarker of cortisol-linked stress.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The concept of chronic stress as a risk factor for atherosclerosis
has been suggested in both animal [1] and human studies [2,3].
Despite many years of research, it remains difﬁcult to precisely
assess chronic stress in humans due tomeasurement errors on self-
reported questionnaires (validity concerns) and the inability of
short-term measures of stress hormones (e.g., cortisol levels) toMedicine, Feinberg School of
Shore Drive, Suite 1400, Chi-
. Greenland).
Ireland Ltd. This is an open accessreﬂect the chronic state or trait. These problems may explain why
the association between chronic stress and atherosclerosis has
been inconsistent in human studies [4].
The cortisol/testosterone (C/T) ratio has been used as a chronic
biomarker of stress, and has been suggested to be a better predictor
of coronary heart disease than cortisol alone [4]. There are several
reasons why the C/T ratio might be a plausible indicator of chronic
stress. Testosterone and cortisol are derived from the same
biochemical precursor [5], so if cortisol synthesis increases, there
will be a corresponding decline in testosterone synthesis because it
is a competitive reaction process [4e6]. Cortisol can suppress the
activity of the hypothalamic-pituitary-gonadal axis [7]. Cortisol has
a catabolic effect, and testosterone has anabolic effects [4].article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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dynamics than cortisol alone.
The aim of this study was to examine the associations of cortisol
alone, testosterone alone, and the C/T ratio with subclinical
atherosclerosis in women. We also studied C/sex hormone-binding
globulin (SHBG) ratio to provide a more complete physiologic
assessment because SHBG has a physiologic role of reducing free
circulating testosterone in women [8,9]. Subclinical atherosclerosis
was assessed using coronary artery calcium (CAC) and carotid
intima-media thickness (IMT).
2. Material and methods
2.1. The coronary artery risk development in young adults (CARDIA)
study
The CARDIA study is a multicenter, longitudinal cohort study of
the development of coronary artery disease risk factors in young
adults. A full description of the study design is published elsewhere
[10]. The full CARDIA cohort included 5115 black and white adults
aged 18e30 years at the year 0 examination (1985e1986), recruited
from four metropolitan areas in the United States (Birmingham, AL;
Chicago, IL; Minneapolis, MN; and Oakland, CA) [11]. Within each
center, the sample was designed to comprise approximately equal
numbers of participants by sex, race (self-deﬁned: black or white),
age (18e24 or 25e30 years), and education (high school or >high
school) [11]. Follow-up examinations (follow-up rates) were con-
ducted at years 2 (91%), 5 (86%), 7 (81%),10 (79%),15 (74%), 20 (72%),
and 25 (72%). All examinations were approved by institutional re-
view boards at each institution, and informed consent was ob-
tained from each study participant [11].
2.2. Study population
For this sub-study, we utilized data from two CARDIA ancillary
studies that measured cortisol, testosterone, and SHBG to test our
hypothesis. One ancillary study was conducted in year 15 at the
Oakland and Chicago sites and included salivary cortisol measure-
ment [12]. The second ancillary study was conducted in year 16 and
included sex hormones and SHBG measurements. Together, the 2
studies provided a total of 367 women who deﬁned the sub-study
population. Of these 367 women (age range 32e51, mean age 40
years old), 28 were missing all data on IMT measurements
(resulting N ¼ 339). Additionally 5 were missing data on con-
founding variables, and 27 were missing some but not all IMT
measures. For the CAC analysis, 320 women had CAC data from
both years 15 and 25, of whom 17 already had positive CAC ﬁndings
at year 15. Therefore, 303 women were included in the analysis
assessing CAC incidence fromyear 15 to year 25. Fig.1 illustrates the
study population.
2.3. Cortisol, testosterone, and ratios
The detailed cortisol measurement protocol was described
elsewhere [13]. Participants were given materials and instructed
regarding the collection of saliva samples at the conclusion of their
year 15 follow-up CARDIA clinic visit [13]. Samples were collected
from participants on a single weekday, in most cases the Monday
after a Friday or Saturday clinic visit [13]. Participants were
instructed not to eat, brush their teeth, or drink liquids for at least
15 min before collecting a sample [14]. They were provided six
saliva sample containers to be used over the course of the day:
upon awakening (“when your eyes open and you are ready to get
up”), 45 min, 2.5 h, 8 h, and 12 h after awakening, and at bedtime
(“right before getting into bed”) [13]. Participants were instructedto record the time they woke up in a log and were provided alarm
watches (preset to their regular wakeup time) to remind them to
collect samples; they were also given a form that allowed them to
easily recalculate the desired sample times if they woke up at a
different time than anticipated [13]. Cortisol concentrations were
determined by time-resolved immunoassays with ﬂuorometric end
point detection [13]. Intra- and interassay variabilities were each
less than 12%.
Area under the curve (AUC) for cortisol, a time-adjusted mea-
sure of total cortisol exposure while awake, is thought to reﬂect
cumulative tissue exposure to cortisol across the day; persistently
high total daily output may create “wear and tear” on various body
tissues, resulting in structural or functional changes that could
affect disease vulnerability [15]. On the other hand, the additional
use of diurnal slopes attempts to capture cortisol circadian ﬂuctu-
ation patterns. The slope is usually operationally deﬁned as the line
resulting from regression of cortisol values collected across the day
onto hours since awakening excluding the morning awakening
response [15]. A negative diurnal slope is generally considered
indicative of healthy hypothalamus-pituitary-adrenal (HPA) axis
function, with a ﬂattened or positive diurnal slope suggestive of
potential HPA axis dysfunction [15]. AUC and slope were chosen for
the chronic cortisol indices because they have greater 12-month
stability than cortisol awakening response [15]. One study re-
ported 12-month intra-class correlation coefﬁcients for AUC of
about 0.5 and for slope of about 0.25 [15].
The AUC for cortisol was calculated as the plot of log-
transformed cortisol values against collection times from the ﬁrst
to the last sample [13]. The AUC was computed only for those
people who had data for the ﬁrst sample and a minimum of 12 h
between their ﬁrst and last samples [13]. The cortisol slope was
calculated for those who had the ﬁrst sample and the sixth sample
as reported previously [13]. All 367 women in the substudy had
both 1st and 6th samples. The slope was estimated by separately
ﬁtting a linear regression line for each participant that predicted
the log-transformed cortisol concentrations from time (hours)
since awakening [13]. To minimize the impact of morning rise in
cortisol on slope estimation, the second saliva samplewas excluded
from the slope calculation [13].
Detailed testosterone and SHBG measurement protocols are
published elsewhere [16]. Brieﬂy, SHBG, total testosterone, and free
testosterone were measured in a single batch on serum specimens
collected at year 16 in the CARDIAWomen's Study [16]. SHBG was
determined using equilibrium dialysis on a Sephadex G-25 column
[16]. This method estimates the amount of testosterone capable of
being bound by SHBG [16]. Total testosterone was measured with a
competitive immunoassay (Bayer Diagnostics, Tarrytown, NY) that
employed direct chemiluminescent technology on the ACS:180
automated chemiluminescent system (Beckman Coulter, Brea, CA).
The coefﬁcient of variation for the total testosterone sample (80 ng/
dL) was 5.9%. The manufacturer, Beckman Coulter, reports that the
coefﬁcient of variation (CV) for this assay is less than 10% for total
testosterone >50 ng/dL, while The College of American Pathologists
document an inter-assay CV of 13.4% for 30 ng/dL samples with the
Beckman Coulter system, the lowest of 16 systems surveyed [16].
Due to imprecision at the lower end of the detection limit of the
assay, total testosterone levels below 10.0 ng/dL were all reported
as 5 ng/dL [16]. Free testosterone which is used for estimation of
free testosterone level in women [9] was calculated based on
measured total testosterone and SHBG levels using the method
described by Pearlman [16,17]. The analyses only included mea-
sures obtained from women who reported that they were not
pregnant.
The following ratios of AUC and of slope of cortisol to total
testosterone, free testosterone, and SHBG were computed: AUC/
Fig. 1. Flow chart of participants for analyses in the CARDIA cortisol/testosterone substudy.
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testosterone, slope/free testosterone, and slope/SHBG.
2.4. Measures of subclinical atherosclerosis (CAC, IMT)
Subclinical atherosclerosis was measured using 2 techniques
(CAC, carotid IMT). First, CAC was measured at the CARDIA follow-
up examinations at years 15, 20, and 25 [18]. CACmeasurement was
performed with an electrocardiographically gated multidetector
computed tomography scanner with a standard phantom for cali-
bration using a standardized protocol [19] with published accuracy,
comparability, and reproducibility [18,20,21]. Brieﬂy, scans were
obtained, and image analysts (blinded to participant characteris-
tics) calculated a total CAC score using a modiﬁed Agatston method
with select overreading by a physician who was an expert in car-
diovascular imaging [18]. The presence of CAC is deﬁned as an
Agatston score greater than 0 (CAC negative stands for a score of
zero, whereas any value above zerowas considered as CAC positive)
[16,22] as previously suggested to predict CVD in low-risk women
[16,23]. Incident CAC from year 15e25 was deﬁned as no CAC at
year 15 and newly developed CAC at year 25. We also performed
analyses for associations with prevalent CAC at years 15, 20, and 25.
IMT measures of the common carotid artery (CCA), carotid bulb
(CB), and internal carotid artery (ICA) were obtained at the CARDIA
follow-up year 20 examination [16]. Carotid B-mode ultrasound
examinations were conducted by trained sonographers at each
ﬁeld center employing a standard protocol using the GE Logiq 700
device (GE Medical Systems, Wauwatosa, WI). The carotid ultra-
sound procedures were performed in the supine position with the
participant's head rotated 45 away from the side of study.
Magniﬁed longitudinal images in gray-scale of the far and near wall
of the distal CCA, CB, and proximal ICA were obtained on the right
and left sides. Images were read at the ultrasound central reading
center (Tufts Medical Center, Boston, MA) by individuals blinded to
all clinical information. The maximum IMT of each segment was
deﬁned as the mean of the maximal IMT of the near and far walls of
both the left and right sides.
2.5. Confounders and covariates
Demographic measures included age, sex, and race obtained at
the year 15 examination by self-report. Height and weight were
measured with the participant wearing light clothing with no
shoes, and body mass index (BMI) was computed by dividing the
weight (kg) by the height squared (m2). Seated blood pressure (BP)
was measured using a random zero sphygmomanometer for theyear 15 examination [18]. After a 5-min rest in a quiet room, blood
pressure was measured on the right arm at three 1-min intervals;
the average of the second and third measurements was used [18].
Menopausal status was self-reported. Use of oral contraceptives
(yes, no, or missing) was obtained at exam year 16. Glucose was
assayed using hexokinase coupled to glucose-6 phosphate dehy-
drogenase. Diabetes was deﬁned by fasting glucose 126 mg/dL or
medication use [24]. Cigarettes smoked per day were self-reported
at the year 15 examination. Alcohol intake (ml/d) was computed
from self-reported frequency of consumption of beer, wine, and
liquor per week at the year 15 examination [25].
2.6. Statistical analysis
Data are presented as means and standard deviations or pro-
portions. The associations of C/T and C/SHBG, categorized into
tertiles, with CAC and IMT were assessed by logistic regression
analysis (CAC) and multiple linear regression (IMT). Model I
controlled for age and race. Model II controlled for model I variables
plus body mass index (BMI), systolic blood pressure (BP), meno-
pause, oral contraceptive usage, diabetes mellitus, alcohol con-
sumption, and cigarette smoking. We additionally analyzed for
dose-response relationship on incident CAC by trend test across
tertiles (that is, by assigning the median AUC/hormone or slope/
hormone value of each tertile as its value and treating this as a
continuous variable in the regressionmodel). All statistical analyses
were performed using SAS version 9.4 (SAS Inc., Cary, NC, USA). A
two-tailed test with p < 0.05 was considered to be statistically
signiﬁcant.
3. Results
The study participants' characteristics at year 15 are shown in
Table 1. Participants mean age was 40 years old (range 32e51) and
59.4% reported black race.
3.1. Associations with prevalent CAC
The prevalence of CAC at year 25was 16.6% (N¼ 54). The highest
tertile of AUC/SHBG ratio was associated with year 25 CAC preva-
lence inmodel I (OR 2.28, 95% CI 1.05e4.95). The associationwas no
longer signiﬁcant after adjusting for age, race, menopause, oral
contraceptive use, BMI, systolic BP, diabetes, alcohol drinking, and
cigarette smoking (OR 1.76, 95% CI 0.70e4.42). (Data are not shown
in the tables). Separate analyses of the unadjusted and adjusted
associations of AUC of cortisol, slope of cortisol, total testosterone,
Table 1
Baseline characteristics in the 367 CARDIA females in the sub-study of cortisol/
testosterone ratio.
Variable
Age, mean years ±S.D. 40.23 ± 3.66
Race, black number (%) 218 (59.40%)
Menopause, number (%) 28 (7.63%)
Cortisol (AUC), nmol/hour, logged, mean ± S.D. 2.08 ± 0.51
Cortisol (Slope), nmol/hour, logged, mean ± S.D. 0.08 ± 0.06
Total testosteronea, ng/dL mean ± S.D. 24.58 ± 19.22
Free testosteronea, ng/dL mean ± S.D. 0.19 ± 0.15
SHBGa, nmol/liter mean ± S.D. 28.13 ± 13.15
Oral contraceptive usea, number (%) 58 (15.85%)
Body mass index, kg/m2 mean ± S.D. 30.10 ± 8.42
Systolic BP, mmHg mean ± S.D. 113.34 ± 15.28
Diabetes Mellitus, number (%) 24 (6.56%)
Cigarette smoking, cigarettes/day mean ± S.D. 2.06 ± 5.33
Alcohol drinking, ml/day mean ± S.D. 6.67 ± 15.47
a Results from Year 16.
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tistically signiﬁcant associations (Supplementary Table 1).3.2. Associations with incident CAC
The incidence of new CAC between years 15e25 was 12.5%
(N¼ 38). The highest tertile of the AUC/free testosterone ratio had a
nonsigniﬁcant OR with incident CAC from year 15e25 in model I
(Table 2, OR 2.22, 95% CI 0.89e5.51) and had a signiﬁcant positive
association in model II (OR 3.45, 95% CI 1.18e10.06). In model II, the
AUC/free testosterone ratio showed a dose-response relationship
with the second tertile being intermediate between the ﬁrst and
third tertiles (p for trend ¼ 0.04). Associations of slope/total
testosterone, slope/free testosterone, and slope/SHBGwith incident
CAC were not signiﬁcant (Supplementary Table 2). Separate ana-
lyses of AUC for cortisol, slope of cortisol, total testosterone, free
testosterone, and SHBG with CAC incidence showed no statistically
signiﬁcant associations (Supplementary Table 3).Table 2
Odds ratios for incident coronary artery calciﬁcation between year 15 and 25 and
AUC of cortisol/T (or AUC of cortisol/SHBG) ratio.
Ratio Year 15e25 incidence (N ¼ 38)
Model Ia (N ¼ 302)b Model IIc (N ¼ 299)d
OR 95% CI P Trend OR 95% CI P trend
AUC/total testosterone
Tertile 1 1.00 Reference 0.36 1.00 Reference 0.15
Tertile 2 1.51 (0.61e3.74) 1.24 (0.46e3.34)
Tertile 3 1.68 (0.69e4.07) 2.01 (0.75e5.44)
AUC/free testosterone
Tertile 1 1.00 Reference 0.15 1.00 Reference 0.04
Tertile 2 1.82 (0.70e4.70) 2.21 (0.77e6.33)
Tertile 3 2.22 (0.89e5.51) 3.45 (1.18e10.06)
AUC/SHBG
Tertile 1 1.00 Reference 0.04 1.00 Reference 0.09
Tertile 2 1.27 (0.48e3.35) 0.79 (0.26e2.41)
Tertile 3 2.45 (0.98e6.13) 1.98 (0.69e5.66)
Abbreviation C/T ratio; cortisol/testosterone ratio, SHBG; sex hormone binding
globulin, AUC; area under the curve of six salivary cortisol.
a Adjusted for age, race.
b One person out of 303 is missing AUC.
c Adjusted for age, race, menopause, oral contraceptive use, BMI, systolic BP,
diabetes, alcohol drinking, and cigarette smoking.
d 3 people were missing data on confounders or covariates.3.3. Associations with carotid IMT
Table 3 and Supplementary Table 4 show the associations be-
tween IMT and C/T (or SHBG) ratio. We observed some signiﬁcant
associations in model I. AUC/free testosterone, which was associ-
ated with incident CAC (Table 2), was also associated with the year
20 average maximum CB in both model I (b ¼ 0.068, p ¼ 0.03) and
model II (b ¼ 0.088, p < 0.01, Table 3). In model II, the AUC/free
testosterone ratio showed a dose-response relationship with the
second tertile (b¼ 0.059, p¼ 0.05) being intermediate between the
ﬁrst and the third tertiles. Separate analyses of AUC of cortisol,
slope of cortisol, total testosterone, free testosterone, and SHBG
with IMT prevalence are shown in Supplementary Table 5, and no
signiﬁcant results were found. The second and third tertiles of
SHBG were associated with the average maximum CB. The highest
free testosterone tertile was inversely associated with average
maximum CB.
4. Discussion
In this CARDIA substudy of U.S. middle-age black and white
women, we examined the associations between various C/T ratios
and prospective incident CAC and carotid IMT. There were no sig-
niﬁcant associations with incident CAC or IMT for most of the C/T
ratios. We found signiﬁcant associations for: 1) highest tertile of
AUC/free testosterone ratio with incident CAC in model II, 2)
highest tertile of AUC/free testosterone ratio with IMT of carotid
bulb in models I and II, 3) 2nd tertile of slope/total testosterone
ratio with IMTof CCA and ICA in model I, 4) 2nd tertile of slope/free
testosterone ratio with IMT of CCA in models I and II, and 5) 3rd
tertile of slope/free testosterone ratio with IMTof CCA in model I. In
separate analyses of cortisol and testosterone with incident CAC,
we found only non-signiﬁcant results.
To the best of our knowledge, there are no previous studies that
have examined the relationship of the C/T ratio to measures of
subclinical atherosclerosis. However if we expand the endpoint to
include clinical cardiovascular disease, there was one previous
population-based study that showed direct associations between
the serum C/T ratio and incident cardiovascular disease. In the
Caerphilly cohort study [4] (2512men, aged 45e59 years old, with a
mean follow-up of 16.5 years), a positive linear trend was seen
between serum C/T ratio for incident ischemic heart disease (age-
adjusted OR per z score change in ratio 1.22, 95% CI 1.07 to 1.38,
P¼ 0.003). However, after adjustment for confounders, their results
were no longer statistically signiﬁcant.
In contrast to the limited previous research on C/T ratio, many
prior studies have found signiﬁcant associations of SHBG with
subclinical atherosclerosis [16,26]. Although SHBG plays a physio-
logical role of reducing circulatory testosterone level in women
[8,9], there were no previous studies assessing C/SHBG ratio. One of
the earlier ﬁndings from the CARDIA Women's study showed an
inverse association of SHBG (mean value of year 2, 10, and 16) with
both CAC and IMT [16]. This previous study did not ﬁnd a signiﬁcant
association of CAC or IMT with either total testosterone or free
testosterone [16]. Our study had consistent results as the prior
study with total testosterone and free testosterone, but not for
SHBG. In our study, SHBG was positively associated with carotid
bulb IMT; however, we did not ﬁnd the association of SHBG with
incident CAC. Our study also failed to show a signiﬁcant association
of C/SHBG with incident CAC. Possible explanations for the incon-
sistent results within CARDIA include differences in sample sizes
between substudies (our study is 20% of previous study sample size
because of within 1 year cortisol availability), differences in how
CAC and SHBG were characterized (year 2, 10, 16 versus year 16),
and differences in the selection of covariates included in the
Table 3
Beta-coefﬁcients for the associations between intima-media thickness and AUC of cortisol/T (or AUC of cortisol/SHBG) ratio.
Average max CCA (mm) Average max bulb (mm) Average max ICA (mm)
Model Ia
(N ¼ 336)
Model IIb
(N ¼ 331)
Model Ia
(N ¼ 331)
Model IIb
(N ¼ 326)
Model Ia
(N ¼ 315)
Model IIb
(N ¼ 310)
Вeta (s.e) p Вeta (s.e) p Вeta (s.e) p Вeta (s.e) p Вeta (s.e) p Вeta (s.e) p
AUC/TT
Tertile 1 Ref Ref Ref Ref Ref Ref
Tertile 2 0.001
(0.015)
0.95 0.004
(0.014)
0.75 0.038
(0.031)
0.21 0.041
(0.030)
0.17 0.032
(0.027)
0.24 0.023
(0.027)
0.40
Tertile 3 0.028
(0.015)
0.06 0.014
(0.014)
0.33 0.020
(0.031)
0.51 0.037
(0.031)
0.24 0.021
(0.027)
0.44 0.007
(0.028)
0.80
AUC/FT
Tertile 1 Ref Ref Ref Ref Ref Ref
Tertile 2 0.007
(0.015)
0.63 0.018
(0.014)
0.21 0.050
(0.031)
0.11 0.059
(0.031)
0.05 0.019
(0.028)
0.49 0.011
(0.028)
0.71
Tertile 3 0.026
(0.015)
0.09 0.005
(0.015)
0.72 0.068
(0.032)
0.03 0.088
(0.032)
<0.01 0.010
(0.028)
0.72 0.010
(0.029)
0.72
AUC/SHBG
Tertile 1 Ref Ref Ref Ref Ref Ref
Tertile 2 0.028
(0.015)
0.06 0.001
(0.015)
0.96 0.005
(0.031)
0.88 0.021
(0.032)
0.50 0.042
(0.027)
0.12 0.015
(0.028)
0.61
Tertile 3 0.020
(0.015)
0.20 0.016
(0.016)
0.30 0.012
(0.032)
0.70 0.046
(0.034)
0.17 0.019
(0.028)
0.50 0.017
(0.031)
0.59
Abbreviation C/T ratio; cortisol/testosterone ratio, SHBG; sex hormone binding globulin, AUC; area under the curve of six salivary cortisol, TT: total testosterone, FT; Free
testosterone, CCA; common carotid artery, Bulb; carotid bulb, ICA; internal carotid artery.
a Adjusted for age, race.
b Adjusted for age, race, menopause, oral contraceptive use, BMI, systolic BP, diabetes, alcohol drinking, and cigarette smoking.
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The present study has several strengths. This is the ﬁrst study
assessing the C/T ratio (and C/SHBG ratio) in women, and it is also
the ﬁrst to demonstrate an association between the C/T ratio and
subclinical atherosclerosis using data from a carefully conducted
epidemiologic U.S. study. We analyzed both prospective IMT and
incident CAC, which are separate but complementary measures of
subclinical atherosclerosis. Notably, we performed six salivary
cortisol measurements in a single day rather than one measure of
serum cortisol. Since cortisol exhibits a marked diurnal pattern,
multiple measurements as reported here provide a more complete
assessment of cortisol secretion.
It is worth considering why C/T ratio may improve prediction
compared to either measure alone. Testosterone and cortisol are
derived from the same biochemical precursor [5], and secretion of
cortisol and testosterone are inversely related [4]: If cortisol syn-
thesis increases, testosterone synthesis should decline because it is
a competitive reaction [4e6]. Recent studies have demonstrated
additional inter-relationships of cortisol and testosterone [7]. In the
presence of cortisol elevation due to chronic stress via
hypothalamic-pituitary-adrenal axis [27], cortisol affects testos-
terone in multiple ways [7] (Fig. 2). Cortisol suppresses the activity
of hypothalamic-pituitary-gonadal axis, cortisol inhibits the action
of testosterone on target tissue, and cortisol down regulates
androgen receptors [7]. Accordingly, chronic stress leads to pro-
longed suppression of testosterone function [27]. Therefore the C/T
ratio may capture more accurately endocrine dynamics than
cortisol or testosterone alone. The connection between the C/T ratio
and atherosclerosis is plausible through insulin resistance [4] and
inﬂammation [28]. Cortisol is associated with an adverse effect
(catabolic) on insulin resistance and cardiovascular risk factors (e.g.
lipids), and testosterone is associated with favorable (anabolic)
effects [4]. Also, it is possible that stress itself increases the prolif-
eration of primitive hematopoietic progenitors, giving rise to
higher levels of disease-promoting inﬂammatory leukocytes [28].
In a study of atherosclerosis-prone Apolipoprotein E (/) mice,
chronic stress accelerated hematopoiesis and promoted plaquefeatures associated with lesions that cause myocardial infarction
and stroke in humans [28].
We can only speculate as to why only the AUC of cortisol was
signiﬁcantly associated with both of the atherosclerosis measures
(CAC and IMT) whereas slope of cortisol was not signiﬁcant for
both. The AUC is thought to reﬂect cumulative tissue exposure to
cortisol across the day; persistently high total daily output may
create “wear and tear” in various body tissues, resulting in struc-
tural or functional changes that could affect disease vulnerability
[15]. On the other hand, diurnal slope attempts to capture a char-
acteristic of the cortisol circadian pattern [15]. Abnormal patterns
of cortisol slope (ﬂat slope) can occur for a number of reasons. In
some people, cortisol does not return to baseline levels as one
would expect over the course of the day (high level). In other in-
dividuals, there may be a failure to exhibit the usual cortisol
awakening response and thus cortisol in these people is low
throughout the day. These opposite patterns may have the same
cortisol slope but very different cortisol AUC. It is also worth
considering why only the AUC/free testosterone ratio was signiﬁ-
cant whereas AUC/total testosterone and AUC/SHBG were not sig-
niﬁcant. We used total and free testosterone measurements for
calculating C/T ratios. Total testosterone measures all circulating
forms of testosterone, whereas free testosterone measures only the
unbound form of testosterone. Although they are both measure-
ments of testosterone, physiologic functions are different. Free
testosterone is the biologically active form; therefore the AUC/free
testosterone ratio possibly represents the most physiologically
appropriate measure. It is also possible that cortisol/testosterone
regulation is due to mechanisms other than SHBG binding in
women [8,9] (Fig. 2) such as downregulation of the androgen re-
ceptor or inhibition of the action of T on target tissue [7]. Therefore,
this may account for the observation here that AUC/SHBG did not
show signiﬁcant results.
Several limitations should be considered. First, the sample size is
small due to combining two ancillary studies. Second, we used year
15 cortisol and year 16 testosterone and SHBG. According to a
previously reported study of cortisol stability [15,29], the 12-month
Fig. 2. Possible mechanisms associated with cortisol/testosterone ratio.
J.-M. Lee et al. / Atherosclerosis 248 (2016) 203e209208intraclass correlation coefﬁcient is about 0.5 for AUC [15], and about
0.25 for the slope [15], so our inability to utilize concurrent results
may haveweakened the associations. Third, the majority of women
(92%) were premenopausal with low total testosterone and free
testosterone levels. Fourth, we adjusted for a large numbers of
confounders and covariates given the size of our study population.
These limitations may also have weakened the associations. How-
ever, the signiﬁcant results may show genuine relationships
considering biological mechanisms.
In conclusion, the AUC/free testosterone ratio may be a better
indicator of subclinical atherosclerosis than either cortisol or
testosterone alone, and the highest tertile of AUC/free testosterone
ratio may be positively associated with subclinical atherosclerosis.
If this ﬁnding is replicated in other studies, the AUC/free testos-
terone ratio may be a useful measure of cortisol linked chronic
stress in population studies. In addition, our ﬁndings suggest that
this measure of chronic stress is associated with some measures of
subclinical atherosclerosis in young women.
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